Nadia Smaili and Paulina Arroyo Pardo do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.
Université du Québec à Montréal (UQAM) provides funding as a founding partner of The Conversation CA-FR.
Université du Québec à Montréal (UQAM) provides funding as a member of The Conversation CA.
EDHEC Business School and AUF (Agence Universitaire de la Francophonie) provide funding as members of The Conversation FR.
Republish our articles for free, online or in print, under a Creative Commons license.
Whistleblower rights are on the rise, it seems. In February 2023, the Grand Chamber of the European Court of Human Rights overturned an earlier criminal conviction of Raphaël Halet, one of the LuxLeaks whistleblowers that disclosed tax avoidance practices at PricewaterhouseCoopers.
Meanwhile in France, the Mediator drug case still drags on after more than a decade. Pharmaceutical firm Servier recently launched an appeal against convictions it was handed in 2021 for concealing the risks of the Mediator weight-loss pill. Irène Frachon, the doctor that discovered the drug’s potentially fatal side effects, still maintains her courageous whistleblowing efforts.
The protection of whistleblowers in Europe is about to get another boost. In transposing the EU Whistleblowing Directive,...
Dangote Group has dismissed as false and malicious a publication alleging that its President, Aliko Dangote, distanced himself from Tony Elumelu, describing the report as entirely baseless. In a s...